Aristotle Capital Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Aristotle Capital Management’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,584	Closed	-$233K	–	132
2015 Q2	$233K	Hold	2,584	–	–	﹤0.01%	123
2015 Q1	$260K	Hold	2,584	–	–	﹤0.01%	126
2014 Q4	$260K	Hold	2,584	–	–	﹤0.01%	131
2014 Q3	$249K	Hold	2,584	–	–	﹤0.01%	134
2014 Q2	$241K	Hold	2,584	–	–	﹤0.01%	152
2014 Q1	$215K	Hold	2,584	–	–	﹤0.01%	135
2013 Q4	$216K	Buy	+2,584	New	+$210K	﹤0.01%	134
2013 Q3	–	Sell	-2,584	Closed	-$205K	–	137
2013 Q2	$205K	Buy	+2,584	New	+$207K	0.01%	130

Other funds holding MJN

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Aristotle Capital Management's MJN Position: Q3 2015 in Review

Aristotle Capital Management sold out of Mead Johnson Nutrition Company (MJN) in Q3 2015, closing a stake of 2,584 shares — an estimated $233K sold.

Aristotle Capital Management first reported a position in MJN in Q2 2013 and held it in 8 quarters. The position peaked at $260K in Q1 2015. 532 funds tracked by Wall St. Rank hold MJN as of Q3 2015.

Aristotle Capital Management reported no remaining Mead Johnson Nutrition Company position as of Q3 2015 after selling out during the quarter.
Aristotle Capital Management sold 2,584 Mead Johnson Nutrition Company shares in Q3 2015, an estimated $233K.
Aristotle Capital Management first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 8 quarters.
Aristotle Capital Management's Mead Johnson Nutrition Company position peaked at $260K in Q1 2015.
532 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2015.

Based on Aristotle Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.